Trial · NCT01831817
Adverse events68
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 68
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Headache | Nervous system disorders | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 1 | 35 | 2 |
| other | Headache | Nervous system disorders | 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 2 | 34 | 2 |
| other | Headache | Nervous system disorders | Sodium Monofluorophosphate | 1 | 35 | 1 |
| other | Headache | Nervous system disorders | Sodium Fluoride | 2 | 36 | 2 |
| other | Arthralgia | Immune system disorders | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 1 | 35 | 1 |
| other | Arthralgia | Immune system disorders | 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0 | 34 | 0 |
| other | Arthralgia | Immune system disorders | Sodium Monofluorophosphate | 0 | 35 | 0 |
| other | Arthralgia | Immune system disorders | Sodium Fluoride | 0 | 36 | 0 |
| other | Constipation | Gastrointestinal disorders | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 1 | 35 | 1 |
| other | Constipation | Gastrointestinal disorders | 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0 | 34 | 0 |
| other | Constipation | Gastrointestinal disorders | Sodium Monofluorophosphate | 0 | 35 | 0 |
| other | Constipation | Gastrointestinal disorders | Sodium Fluoride | 0 | 36 | 0 |
| other | Pain in Jaw | General disorders | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0 | 35 | 0 |
| other | Pain in Jaw | General disorders | 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0 | 34 | 0 |
| other | Pain in Jaw | General disorders | Sodium Monofluorophosphate | 0 | 35 | 0 |
| other | Pain in Jaw | General disorders | Sodium Fluoride | 1 | 36 | 1 |
| other | Oral Herpes | Infections and infestations | 5% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 1 | 35 | 1 |
| other | Oral Herpes | Infections and infestations | 0% Calcium Sodium Phosphosilicate/ Sodium Monofluorophosphate | 0 | 34 | 0 |
| other | Oral Herpes | Infections and infestations | Sodium Monofluorophosphate | 0 | 35 | 0 |
| other | Oral Herpes | Infections and infestations | Sodium Fluoride | 0 | 36 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01831817/events